-
1
-
-
85044279631
-
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
-
Jia, W.; Xie, G.; Jia, W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat. Rev. Gastroenterol. Hepatol. 2017, 15, 111–128. [CrossRef] [PubMed]
-
(2017)
Nat. Rev. Gastroenterol. Hepatol.
, vol.15
, pp. 111-128
-
-
Jia, W.1
Xie, G.2
Jia, W.3
-
2
-
-
84991736278
-
Role of epithelial to mesenchymal transition in hepatocellular carcinoma
-
Giannelli, G.; Koudelkova, P.; Dituri, F.; Mikulits, W. Role of epithelial to mesenchymal transition in hepatocellular carcinoma. J. Hepatol. 2016, 65, 798–808. [CrossRef] [PubMed]
-
(2016)
J. Hepatol.
, vol.65
, pp. 798-808
-
-
Giannelli, G.1
Koudelkova, P.2
Dituri, F.3
Mikulits, W.4
-
3
-
-
0033591297
-
Identification of a nuclear receptor for bile acids
-
Makishima, M.; Okamoto, A.Y.; Repa, J.J.; Tu, H.; Learned, R.M.; Luk, A.; Hull, M.V.; Lustig, K.D.; Mangelsdorf, D.J.; Shan, B. Identification of a nuclear receptor for bile acids. Science 1999, 284, 1362–1365. [CrossRef] [PubMed]
-
(1999)
Science
, vol.284
, pp. 1362-1365
-
-
Makishima, M.1
Okamoto, A.Y.2
Repa, J.J.3
Tu, H.4
Learned, R.M.5
Luk, A.6
Hull, M.V.7
Lustig, K.D.8
Mangelsdorf, D.J.9
Shan, B.10
-
4
-
-
0033591387
-
Bile acids: Natural ligands for an orphan nuclear receptor
-
Parks, D.J.; Blanchard, S.G.; Bledsoe, R.K.; Chandra, G.; Consler, T.G.; Kliewer, S.A.; Stimmel, J.B.; Willson, T.M.; Zavacki, A.M.; Moore, D.D.; et al. Bile acids: Natural ligands for an orphan nuclear receptor. Science 1999, 284, 1365–1368. [CrossRef] [PubMed]
-
(1999)
Science
, vol.284
, pp. 1365-1368
-
-
Parks, D.J.1
Blanchard, S.G.2
Bledsoe, R.K.3
Chandra, G.4
Consler, T.G.5
Kliewer, S.A.6
Stimmel, J.B.7
Willson, T.M.8
Zavacki, A.M.9
Moore, D.D.10
-
5
-
-
0033026760
-
Endogenous bile acids are ligands for the nuclear receptor FXR/BAR
-
Wang, H.; Chen, J.; Hollister, K.; Sowers, L.C.; Forman, B.M. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell 1999, 3, 543–553. [CrossRef]
-
(1999)
Mol. Cell
, vol.3
, pp. 543-553
-
-
Wang, H.1
Chen, J.2
Hollister, K.3
Sowers, L.C.4
Forman, B.M.5
-
6
-
-
84905257719
-
Bile acid signaling in metabolic disease and drug therapy
-
Li, T.; Chiang, J.Y. Bile acid signaling in metabolic disease and drug therapy. Pharmacol. Rev. 2014, 66, 948–983. [CrossRef] [PubMed]
-
(2014)
Pharmacol. Rev.
, vol.66
, pp. 948-983
-
-
Li, T.1
Chiang, J.Y.2
-
7
-
-
85014688842
-
Farnesoid X receptor an emerging target to combat obesity
-
De Magalhaes Filho, C.D.; Downes, M.; Evans, R.M. Farnesoid X receptor an emerging target to combat obesity. Dig. Dis. 2017, 35, 185–190. [CrossRef] [PubMed]
-
(2017)
Dig. Dis.
, vol.35
, pp. 185-190
-
-
de Magalhaes Filho, C.D.1
Downes, M.2
Evans, R.M.3
-
8
-
-
84929266699
-
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multicentre, randomised, placebo-controlled trial
-
Neuschwander-Tetri, B.A.; Loomba, R.; Sanyal, A.J.; Lavine, J.E.; Van Natta, M.L.; Abdelmalek, M.F.; Chalasani, N.; Dasarathy, S.; Diehl, A.M.; Hameed, B.; et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multicentre, randomised, placebo-controlled trial. Lancet 2015, 385, 956–965. [CrossRef]
-
(2015)
Lancet
, vol.385
, pp. 956-965
-
-
Neuschwander-Tetri, B.A.1
Loomba, R.2
Sanyal, A.J.3
Lavine, J.E.4
van Natta, M.L.5
Abdelmalek, M.F.6
Chalasani, N.7
Dasarathy, S.8
Diehl, A.M.9
Hameed, B.10
-
9
-
-
84982102773
-
A placebo-controlled trial of obeticholic acid in primary biliary cholangitis
-
Nevens, F.; Andreone, P.; Mazzella, G.; Strasser, S.I.; Bowlus, C.; Invernizzi, P.; Drenth, J.P.; Pockros, P.J.; Regula, J.; Beuers, U.; et al. A placebo-controlled trial of obeticholic acid in primary biliary cholangitis. N. Engl. J. Med. 2016, 375, 631–643. [CrossRef] [PubMed]
-
(2016)
N. Engl. J. Med.
, vol.375
, pp. 631-643
-
-
Nevens, F.1
Andreone, P.2
Mazzella, G.3
Strasser, S.I.4
Bowlus, C.5
Invernizzi, P.6
Drenth, J.P.7
Pockros, P.J.8
Regula, J.9
Beuers, U.10
-
10
-
-
33645821043
-
Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration
-
Huang, W.; Ma, K.; Zhang, J.; Qatanani, M.; Cuvillier, J.; Liu, J.; Dong, B.; Huang, X.; Moore, D.D. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 2006, 312, 233–236. [CrossRef] [PubMed]
-
(2006)
Science
, vol.312
, pp. 233-236
-
-
Huang, W.1
Ma, K.2
Zhang, J.3
Qatanani, M.4
Cuvillier, J.5
Liu, J.6
Dong, B.7
Huang, X.8
Moore, D.D.9
-
11
-
-
77950616155
-
Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription
-
Chen, W.D.; Wang, Y.D.; Zhang, L.; Shiah, S.; Wang, M.; Yang, F.; Yu, D.; Forman, B.M.; Huang, W. Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription. Hepatology 2010, 51, 953–962. [CrossRef] [PubMed]
-
(2010)
Hepatology
, vol.51
, pp. 953-962
-
-
Chen, W.D.1
Wang, Y.D.2
Zhang, L.3
Shiah, S.4
Wang, M.5
Yang, F.6
Yu, D.7
Forman, B.M.8
Huang, W.9
-
12
-
-
84870489524
-
Promotion of liver regeneration/repair by farnesoid x receptor in both liver and intestine in mice
-
Zhang, L.; Wang, Y.D.; Chen, W.D.; Wang, X.; Lou, G.; Liu, N.; Lin, M.; Forman, B.M.; Huang, W. Promotion of liver regeneration/repair by farnesoid x receptor in both liver and intestine in mice. Hepatology 2012, 56, 2336–2343. [CrossRef] [PubMed]
-
(2012)
Hepatology
, vol.56
, pp. 2336-2343
-
-
Zhang, L.1
Wang, Y.D.2
Chen, W.D.3
Wang, X.4
Lou, G.5
Liu, N.6
Lin, M.7
Forman, B.M.8
Huang, W.9
-
13
-
-
33847044019
-
Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor
-
Yang, F.; Huang, X.; Yi, T.; Yen, Y.; Moore, D.D.; Huang, W. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. Cancer Res. 2007, 67, 863–867. [CrossRef] [PubMed]
-
(2007)
Cancer Res
, vol.67
, pp. 863-867
-
-
Yang, F.1
Huang, X.2
Yi, T.3
Yen, Y.4
Moore, D.D.5
Huang, W.6
-
14
-
-
34447098081
-
Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice
-
Kim, I.; Morimura, K.; Shah, Y.; Yang, Q.; Ward, J.M.; Gonzalez, F.J. Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis 2007, 28, 940–946. [CrossRef] [PubMed]
-
(2007)
Carcinogenesis
, vol.28
, pp. 940-946
-
-
Kim, I.1
Morimura, K.2
Shah, Y.3
Yang, Q.4
Ward, J.M.5
Gonzalez, F.J.6
-
15
-
-
84920964414
-
Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid x receptor reactivation
-
Degirolamo, C.; Modica, S.; Vacca, M.; Di Tullio, G.; Morgano, A.; D’Orazio, A.; Kannisto, K.; Parini, P.; Moschetta, A. Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid x receptor reactivation. Hepatology 2015, 61, 161–170. [CrossRef] [PubMed]
-
(2015)
Hepatology
, vol.61
, pp. 161-170
-
-
Degirolamo, C.1
Modica, S.2
Vacca, M.3
Di Tullio, G.4
Morgano, A.5
D’Orazio, A.6
Kannisto, K.7
Parini, P.8
Moschetta, A.9
-
16
-
-
0034632762
-
Identification of a chemical tool for the orphan nuclear receptor FXR
-
Maloney, P.R.; Parks, D.J.; Haffner, C.D.; Fivush, A.M.; Chandra, G.; Plunket, K.D.; Creech, K.L.; Moore, L.B.; Wilson, J.G.; Lewis, M.C.; et al. Identification of a chemical tool for the orphan nuclear receptor FXR. J. Med. Chem. 2000, 43, 2971–2974. [CrossRef] [PubMed]
-
(2000)
J. Med. Chem.
, vol.43
, pp. 2971-2974
-
-
Maloney, P.R.1
Parks, D.J.2
Haffner, C.D.3
Fivush, A.M.4
Chandra, G.5
Plunket, K.D.6
Creech, K.L.7
Moore, L.B.8
Wilson, J.G.9
Lewis, M.C.10
-
17
-
-
0037101810
-
6α-Ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective fxr agonist endowed with anticholestatic activity
-
Pellicciari, R.; Fiorucci, S.; Camaioni, E.; Clerici, C.; Costantino, G.; Maloney, P.R.; Morelli, A.; Parks, D.J.; Willson, T.M. 6α-Ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective fxr agonist endowed with anticholestatic activity. J. Med. Chem. 2002, 45, 3569–3572. [CrossRef] [PubMed]
-
(2002)
J. Med. Chem.
, vol.45
, pp. 3569-3572
-
-
Pellicciari, R.1
Fiorucci, S.2
Camaioni, E.3
Clerici, C.4
Costantino, G.5
Maloney, P.R.6
Morelli, A.7
Parks, D.J.8
Willson, T.M.9
-
18
-
-
0037205046
-
A natural product that lowers cholesterol as an antagonist ligand for FXR
-
Urizar, N.L.; Liverman, A.B.; Dodds, D.T.; Silva, F.V.; Ordentlich, P.; Yan, Y.; Gonzalez, F.J.; Heyman, R.A.; Mangelsdorf, D.J.; Moore, D.D. A natural product that lowers cholesterol as an antagonist ligand for FXR. Science 2002, 296, 1703–1706. [CrossRef] [PubMed]
-
(2002)
Science
, vol.296
, pp. 1703-1706
-
-
Urizar, N.L.1
Liverman, A.B.2
Dodds, D.T.3
Silva, F.V.4
Ordentlich, P.5
Yan, Y.6
Gonzalez, F.J.7
Heyman, R.A.8
Mangelsdorf, D.J.9
Moore, D.D.10
-
19
-
-
84937204423
-
Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells
-
Nagahara, T.; Shiraha, H.; Sawahara, H.; Uchida, D.; Takeuchi, Y.; Iwamuro, M.; Kataoka, J.; Horiguchi, S.; Kuwaki, T.; Onishi, H.; et al. Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells. Oncol. Rep. 2015, 34, 1169–1177. [CrossRef] [PubMed]
-
(2015)
Oncol. Rep.
, vol.34
, pp. 1169-1177
-
-
Nagahara, T.1
Shiraha, H.2
Sawahara, H.3
Uchida, D.4
Takeuchi, Y.5
Iwamuro, M.6
Kataoka, J.7
Horiguchi, S.8
Kuwaki, T.9
Onishi, H.10
-
20
-
-
0033636789
-
Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors
-
Lu, T.T.; Makishima, M.; Repa, J.J.; Schoonjans, K.; Kerr, T.A.; Auwerx, J.; Mangelsdorf, D.J. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell 2000, 6, 507–515. [CrossRef]
-
(2000)
Mol. Cell
, vol.6
, pp. 507-515
-
-
Lu, T.T.1
Makishima, M.2
Repa, J.J.3
Schoonjans, K.4
Kerr, T.A.5
Auwerx, J.6
Mangelsdorf, D.J.7
-
21
-
-
77949883895
-
Fak is involved in invasion and metastasis of hepatocellular carcinoma
-
Chen, J.S.; Huang, X.H.; Wang, Q.; Chen, X.L.; Fu, X.H.; Tan, H.X.; Zhang, L.J.; Li, W.; Bi, J. Fak is involved in invasion and metastasis of hepatocellular carcinoma. Clin. Exp. Metastasis 2010, 27, 71–82. [CrossRef] [PubMed]
-
(2010)
Clin. Exp. Metastasis
, vol.27
, pp. 71-82
-
-
Chen, J.S.1
Huang, X.H.2
Wang, Q.3
Chen, X.L.4
Fu, X.H.5
Tan, H.X.6
Zhang, L.J.7
Li, W.8
Bi, J.9
-
22
-
-
84867305638
-
FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model
-
Deuschle, U.; Schüler, J.; Schulz, A.; Schlüter, T.; Kinzel, O.; Abel, U.; Kremoser, C. FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model. PLoS ONE 2012, 7, e43044. [CrossRef] [PubMed]
-
(2012)
Plos ONE
, vol.7
-
-
Deuschle, U.1
Schüler, J.2
Schulz, A.3
Schlüter, T.4
Kinzel, O.5
Abel, U.6
Kremoser, C.7
-
23
-
-
85030527615
-
The FXR agonist, obeticholic acid, suppresses hcc proliferation & metastasis: Role of IL-6/STAT3 signalling pathway
-
Attia, Y.M.; Tawfiq, R.A.; Ali, A.A.; Elmazar, M.M. The FXR agonist, obeticholic acid, suppresses hcc proliferation & metastasis: Role of IL-6/STAT3 signalling pathway. Sci. Rep. 2017, 7, 12502. [PubMed]
-
(2017)
Sci. Rep.
, vol.7
, pp. 12502
-
-
Attia, Y.M.1
Tawfiq, R.A.2
Ali, A.A.3
Elmazar, M.M.4
-
24
-
-
84870481778
-
Downregulation of nuclear receptor FXR is associated with multiple malignant clinicopathological characteristics in human hepatocellular carcinoma
-
Su, H.; Ma, C.; Liu, J.; Li, N.; Gao, M.; Huang, A.; Wang, X.; Huang, W.; Huang, X. Downregulation of nuclear receptor FXR is associated with multiple malignant clinicopathological characteristics in human hepatocellular carcinoma. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 303, G1245–G1253. [CrossRef] [PubMed]
-
(2012)
Am. J. Physiol. Gastrointest. Liver Physiol.
, vol.303
, pp. G1245-G1253
-
-
Su, H.1
Ma, C.2
Liu, J.3
Li, N.4
Gao, M.5
Huang, A.6
Wang, X.7
Huang, W.8
Huang, X.9
-
25
-
-
84883501278
-
Enhanced expression of farnesoid X receptor in human hepatocellular carcinoma
-
Kumagai, A.; Fukushima, J.; Takikawa, H.; Fukuda, T.; Fukusato, T. Enhanced expression of farnesoid X receptor in human hepatocellular carcinoma. Hepatol. Res. 2013, 43, 959–969. [CrossRef] [PubMed]
-
(2013)
Hepatol. Res.
, vol.43
, pp. 959-969
-
-
Kumagai, A.1
Fukushima, J.2
Takikawa, H.3
Fukuda, T.4
Fukusato, T.5
-
26
-
-
84887202124
-
Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling
-
Macha, M.A.; Rachagani, S.; Gupta, S.; Pai, P.; Ponnusamy, M.P.; Batra, S.K.; Jain, M. Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling. Cancer Lett. 2013, 341, 166–177. [CrossRef] [PubMed]
-
(2013)
Cancer Lett
, vol.341
, pp. 166-177
-
-
Macha, M.A.1
Rachagani, S.2
Gupta, S.3
Pai, P.4
Ponnusamy, M.P.5
Batra, S.K.6
Jain, M.7
-
27
-
-
85010420366
-
Overexpression of farnesoid X receptor in small airways contributes to epithelial to mesenchymal transition and COX-2 expression in chronic obstructive pulmonary disease
-
Chen, B.; You, W.J.; Xue, S.; Qin, H.; Zhao, X.J.; Zhang, M.; Liu, X.Q.; Zhu, S.Y.; Jiang, H.D. Overexpression of farnesoid X receptor in small airways contributes to epithelial to mesenchymal transition and COX-2 expression in chronic obstructive pulmonary disease. J. Thorac. Dis. 2016, 8, 3063–3074. [CrossRef] [PubMed]
-
(2016)
J. Thorac. Dis.
, vol.8
, pp. 3063-3074
-
-
Chen, B.1
You, W.J.2
Xue, S.3
Qin, H.4
Zhao, X.J.5
Zhang, M.6
Liu, X.Q.7
Zhu, S.Y.8
Jiang, H.D.9
-
28
-
-
84978835125
-
Bile acids induce activation of alveolar epithelial cells and lung fibroblasts through farnesoid X receptor-dependent and independent pathways
-
Chen, B.; Cai, H.R.; Xue, S.; You, W.J.; Liu, B.; Jiang, H.D. Bile acids induce activation of alveolar epithelial cells and lung fibroblasts through farnesoid X receptor-dependent and independent pathways. Respirology 2016, 21, 1075–1080. [CrossRef] [PubMed]
-
(2016)
Respirology
, vol.21
, pp. 1075-1080
-
-
Chen, B.1
Cai, H.R.2
Xue, S.3
You, W.J.4
Liu, B.5
Jiang, H.D.6
-
29
-
-
84861880073
-
Bile acids acutely stimulate insulin secretion of mouse β-cells via farnesoid x receptor activation and katp channel inhibition
-
Düfer, M.; Hörth, K.; Wagner, R.; Schittenhelm, B.; Prowald, S.; Wagner, T.F.J.; Oberwinkler, J.; Lukowski, R.; Gonzalez, F.J.; Krippeit-Drews, P.; et al. Bile acids acutely stimulate insulin secretion of mouse β-cells via farnesoid x receptor activation and katp channel inhibition. Diabetes 2012, 61, 1479–1489. [CrossRef] [PubMed]
-
(2012)
Diabetes
, vol.61
, pp. 1479-1489
-
-
Düfer, M.1
Hörth, K.2
Wagner, R.3
Schittenhelm, B.4
Prowald, S.5
Wagner, T.F.J.6
Oberwinkler, J.7
Lukowski, R.8
Gonzalez, F.J.9
Krippeit-Drews, P.10
-
30
-
-
85018338007
-
The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
-
Chow, M.D.; Lee, Y.-H.; Guo, G.L. The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Mol. Aspects Med. 2017, 56, 34–44. [CrossRef] [PubMed]
-
(2017)
Mol. Aspects Med.
, vol.56
, pp. 34-44
-
-
Chow, M.D.1
Lee, Y.-H.2
Guo, G.L.3
-
31
-
-
84879888338
-
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
-
Yoshimoto, S.; Loo, T.M.; Atarashi, K.; Kanda, H.; Sato, S.; Oyadomari, S.; Iwakura, Y.; Oshima, K.; Morita, H.; Hattori, M.; et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013, 499, 97–101. [CrossRef] [PubMed]
-
(2013)
Nature
, vol.499
, pp. 97-101
-
-
Yoshimoto, S.1
Loo, T.M.2
Atarashi, K.3
Kanda, H.4
Sato, S.5
Oyadomari, S.6
Iwakura, Y.7
Oshima, K.8
Morita, H.9
Hattori, M.10
-
32
-
-
33847780436
-
Design, synthesis, and evaluation of non-steroidal farnesoid X receptor (FXR) antagonist
-
Kainuma, M.; Makishima, M.; Hashimoto, Y.; Miyachi, H. Design, synthesis, and evaluation of non-steroidal farnesoid X receptor (FXR) antagonist. Bioorg. Med. Chem. 2007, 15, 2587–2600. [CrossRef] [PubMed]
-
(2007)
Bioorg. Med. Chem.
, vol.15
, pp. 2587-2600
-
-
Kainuma, M.1
Makishima, M.2
Hashimoto, Y.3
Miyachi, H.4
-
33
-
-
85042199275
-
Ess2 bridges transcriptional regulators and spliceosomal complexes via distinct interacting domains
-
Takada, I.; Tsuchiya, M.; Yanaka, K.; Hidano, S.; Takahashi, S.; Kobayashi, T.; Ogawa, H.; Nakagawa, S.; Makishima, M. Ess2 bridges transcriptional regulators and spliceosomal complexes via distinct interacting domains. Biochem. Biophys. Res. Commun. 2018, 497, 597–604. [CrossRef] [PubMed]
-
(2018)
Biochem. Biophys. Res. Commun.
, vol.497
, pp. 597-604
-
-
Takada, I.1
Tsuchiya, M.2
Yanaka, K.3
Hidano, S.4
Takahashi, S.5
Kobayashi, T.6
Ogawa, H.7
Nakagawa, S.8
Makishima, M.9
|